Cryo-Cell International, a developer of stem cell solutions, has entered into agreements to launch its proprietary new service, C'elle, in seven countries in Europe, Latin America and Southeast Asia.
Subscribe to our email newsletter
Cryo-Cell has formalized agreements with C’elle distribution partners in the UK, Ireland, Italy, Greece, Venezuela and Panama. Cryo-Cell’s technology license partner, LifeCell Private Ltd has previously announced plans to introduce the C’elle service in India.
With the international launch of C’elle, Cryo-Cell’s global partners will have an opportunity to expand their business models with a proprietary and highly differentiated service. Distribution of the C’elle service outside the US may potentially create new sources of revenue for Cryo-Cell generated from technology license and royalty fees, along with processing and storage revenues for the service, the company said.
Cryo-Cell’s innovative service, introduced in November, 2007, is said to be the first available service that enables women to collect and cryopreserve highly prolific stem cells harvested from menstrual flow.
Mercedes Walton, chairman and CEO of Cryo-Cell, said: “We believe that the globalization of C’elle may generate significant worldwide awareness and interest in the potential of future stem cell therapeutic breakthroughs. We are pleased that our exclusive service, C’elle, will be introduced to women in different countries around the world.
“This exclusive and innovative service, based on Cryo-Cell’s expansive intellectual property portfolio, provides women with the opportunity to store their own stem cells for future potential therapeutic benefit.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.